Given the role of ASXL1 in chromatin modification, we hypothesized that pathogenic ASXL1 variants underlying Bohring-Opitz syndrome (BOS) have a unique DNAm signature. This evidence concerns the gene ASXL1 and Buschke-Ollendorff syndrome.